Lao H. Saal, Ph.D.
Affiliations: | 2007 | Columbia University, New York, NY |
Area:
Molecular Biology, Genetics, Bioinformatics BiologyGoogle:
"Lao Saal"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ramon E. Parsons | grad student | 2007 | Columbia | |
| (Molecular profiling of the PTEN/PI3K pathway in sporadic and hereditary breast carcinoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Meng P, Dalal H, Chen Y, et al. (2024) Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab. Npj Breast Cancer. 10: 14 |
| Dobilas A, Chen Y, Brueffer C, et al. (2023) Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer. Cancer Genomics & Proteomics. 20: 763-770 |
| Li Y, Sundquist K, Vats S, et al. (2023) Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer. Journal of Translational Medicine. 21: 696 |
| Demircan K, Bengtsson Y, Chillon TS, et al. (2023) Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study. Journal of Translational Medicine. 21: 658 |
| Dahlgren M, Lettiero B, Dalal H, et al. (2023) CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer. Bmc Research Notes. 16: 105 |
| Bengtsson Y, Demircan K, Vallon-Christersson J, et al. (2023) Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study. Redox Biology. 63: 102728 |
| Saghir H, Veerla S, Malmberg M, et al. (2022) How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer. Cancers. 14 |
| Demircan K, Sun Q, Bengtsson Y, et al. (2022) Autoimmunity to selenoprotein P predicts breast cancer recurrence. Redox Biology. 53: 102346 |
| Dalal H, Dahlgren M, Gladchuk S, et al. (2022) Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors. Scientific Reports. 12: 4696 |
| Demircan K, Bengtsson Y, Sun Q, et al. (2021) Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study. Redox Biology. 47: 102145 |